DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 156 filers reported holding DIPLOMAT PHARMACY INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $447,000 | -18.1% | 111,800 | +0.3% | 0.00% | – |
| Q3 2019 | $546,000 | -27.8% | 111,450 | -10.3% | 0.00% | – |
| Q2 2019 | $756,000 | +50.6% | 124,200 | +43.8% | 0.00% | – |
| Q1 2019 | $502,000 | -56.8% | 86,400 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $1,163,000 | -57.0% | 86,400 | -38.0% | 0.00% | -50.0% |
| Q3 2018 | $2,703,000 | -28.5% | 139,250 | -5.8% | 0.00% | -33.3% |
| Q2 2018 | $3,780,000 | +52.1% | 147,880 | +19.9% | 0.00% | +50.0% |
| Q1 2018 | $2,486,000 | -31.5% | 123,370 | -31.8% | 0.00% | -33.3% |
| Q4 2017 | $3,631,000 | +151.6% | 180,900 | +159.5% | 0.00% | +200.0% |
| Q3 2017 | $1,443,000 | +43.0% | 69,700 | +2.2% | 0.00% | 0.0% |
| Q2 2017 | $1,009,000 | -13.4% | 68,200 | -6.6% | 0.00% | 0.0% |
| Q1 2017 | $1,165,000 | +26.6% | 73,030 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $920,000 | -98.3% | 73,030 | -96.3% | 0.00% | -97.9% |
| Q3 2016 | $55,547,000 | -28.3% | 1,983,103 | -10.5% | 0.05% | -29.9% |
| Q2 2016 | $77,519,000 | +21.3% | 2,214,823 | -5.1% | 0.07% | +24.1% |
| Q1 2016 | $63,914,000 | -34.7% | 2,332,637 | -18.5% | 0.05% | -34.9% |
| Q4 2015 | $97,899,000 | +13.6% | 2,860,876 | -4.6% | 0.08% | +12.2% |
| Q3 2015 | $86,200,000 | -26.1% | 3,000,358 | +15.1% | 0.07% | -22.9% |
| Q2 2015 | $116,687,000 | +81.3% | 2,607,536 | +40.1% | 0.10% | +84.6% |
| Q1 2015 | $64,352,000 | +801.2% | 1,860,970 | +613.2% | 0.05% | +766.7% |
| Q4 2014 | $7,141,000 | – | 260,921 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|